Mave Health aims to improve attention and mood with its brain-stimulating headset | TechCrunch

"For example, if you ask a psychologist how do you know if a person is making progress, their response to it is very standard, which is that it's not about progress. It's about process [...] But for somebody with depression who is spending a lot of time in therapy, progress is important. So how do you know whether they're making progress or not?"

"In India, committing suicide is a crime, which meant there was police involved, and we had to speak to her psychologist. The answers we got from them made us question if any of it made sense. We started connecting with other psychologists and were getting the same answers."

"The team started to learn more about neuroscience by talking to experts, and soon after realized that while there has been progress around neuromodulation in labs, consumers haven't had the benefit of it."

Mave Health, founded in 2023 by Dhawal Jain, Jai Sharma, and Aman Kumar, created a neuromodulation headset designed to improve attention, mood, and stress regulation while measuring mental health. The founders were motivated by a personal tragedy during COVID-19 lockdowns and identified a critical gap in mental health treatment: the inability to tangibly measure patient progress. Traditional psychologists lacked concrete metrics for assessing improvement, relying instead on process-oriented approaches. After consulting neuroscience experts, the team discovered that while neuromodulation technology had advanced in laboratory settings, consumers lacked access to these innovations. Mave Health positioned its device as a non-medical wearable to circumvent FDA approval requirements, enabling faster market entry in the United States.

Read at TechCrunch